Form 4: Hims & Hers Health CFO Oluyemi Okupe Reports Acquisition of 367,809 Restricted Stock Units

Oluyemi Okupe, CFO of Hims & Hers Health, reports the acquisition of 367,809 Restricted Stock Units (RSUs) tied to Class A Common Stock.

Summary

• Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., filed a Form 4 on March 1, 2024, reporting a transaction that occurred on February 28, 2024.
• The transaction involved the acquisition of 367,809 Restricted Stock Units (RSUs).
• These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
• The RSUs are subject to a 4-year service-based vesting schedule, with equal quarterly installments vesting on March 15, June 15, September 15, and December 15, starting June 15, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to executive compensation. The acquisition of RSUs is generally a positive sign, but it's a routine occurrence.

Positives

• The acquisition of RSUs by a key executive like the CFO can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document outlines the vesting schedule for the acquired RSUs, indicating a long-term incentive structure for the CFO tied to continued service with the company.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. This filing indicates the CFO's increasing stake in the company's equity.

Stakeholder Impact

• The vesting of RSUs aligns the CFO's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates